Abstract
Background
Published data describing the endovascular treatment of dysfunctional mesoportal and portosystemic shunts in the pediatric population are limited.
Objective
We sought to describe the treatment and follow-up of such shunts managed by interventional radiology at a single pediatric hospital. We hypothesized that stenotic and occluded pediatric portosystemic and mesoportal shunts can be maintained patent by interventional radiology in the moderate term.
Materials and methods
We conducted a single-center retrospective study at a tertiary pediatric hospital. We included children with surgical mesoportal (meso-Rex) or portosystemic (mesocaval, splenorenal or splenocaval) shunts treated with attempted angioplasty or stenting from 2010 to 2018. Technical success was defined as catheterization and intervention upon the shunt with venographic evidence of flow improvement. The primary outcome variables were shunt patency at 1 month, 6 months, 12 months and 24 months post-procedure and freedom from reintervention.
Results
Twenty pediatric patients (11 boys, 9 girls; mean age 8.25 years, range 1.3–17 years) met inclusion criteria. Fifty-two interventions (primary and reintervention) on 13 splenorenal, 3 meso-Rex, 2 mesocaval and 2 splenocaval shunts were performed because of evidence of shunt failure, including gastrointestinal bleeding, hypersplenism, or radiographic evidence of a flow defect. The 11 stenotic shunts were treated with 100% technical success, while the remaining 9 occluded shunts were treated with 66.7% technical success. The mean number of reinterventions was 1.9 (standard deviation [SD] = 3.1) per child, which did not differ between stenotic and occluded shunts (P=0.24). Primary patency at 1-month, 6-month, 12-month and 24-months follow-up visits was 17/17 (100%), 10/16 (62.5%), 7/15 (46.7%) and 4/10 (40%), respectively. However, 100% of shunts were either primary patent or primary-assisted patent by endovascular reintervention. There were no cases of shunt occlusion following initial technical success. Finally, the median freedom from reintervention duration was 387 days (SD=821 days).
Conclusion
Dysfunctional portosystemic surgical shunts are effectively managed by endovascular methods. While many shunts require reintervention, combined primary patency and assisted primary patency rates are excellent.
Similar content being viewed by others
References
Shneider BL, Bosch J, De Franchis R et al (2012) Portal hypertension in children: expert pediatric opinion on the report of the Baveno v consensus workshop on methodology of diagnosis and therapy in portal hypertension. Pediatr Transplant 16:426–437
Gauthier F (2005) Recent concepts regarding extra-hepatic portal hypertension. Semin Pediatr Surg 14:216–225
Fuchs J, Warmann S, Kardorff R et al (2003) Mesenterico-left portal vein bypass in children with congenital extrahepatic portal vein thrombosis: a unique curative approach. J Pediatr Gastroenterol Nutr 36:213–216
Mishra PK, Patil NS, Saluja S et al (2016) High patency of proximal splenorenal shunt: a myth or reality? — a prospective cohort study. Int J Surg 27:82–87
Patel N, Grieve A, Hiddema J et al (2017) Surgery for portal hypertension in children: a 12-year review. S Afr Med J 107:12132
Dasgupta R, Roberts E, Superina RA, Kim PC (2006) Effectiveness of rex shunt in the treatment of portal hypertension. J Pediatr Surg 41:108–112
Ketelsen D, Warmann SW, Schaefer JF et al (2012) Percutaneous revascularization of reoccluded meso-rex shunts in extrahepatic portal vein obstruction. J Pediatr Surg 47:E23–E28
Prasad a S, Gupta S, Kohli V et al (1994) Proximal splenorenal shunts for extrahepatic portal venous obstruction in children. Ann Surg 219:193–196
Thornton RH, Kerlan RK, Gordon RL et al (2005) Percutaneous salvage of a failing rex shunt. J Vasc Interv Radiol 16:399–402
Bambini DA, Superina R, Almond PS et al (2000) Experience with the rex shunt (mesenterico-left portal bypass) in children with extrahepatic portal hypertension. J Pediatr Surg 35:13–18
Sancak T, Karagulle AT, Bilgic S et al (2002) Stent angioplasty of closed mesocaval shunt in a patient with Budd-Chiari syndrome. Cardiovasc Intervent Radiol 25:332–334
Ruff RJ, Chuang VP, Alspaugh JP et al (1987) Percutaneous vascular intervention after surgical shunting for portal hypertension. Radiology 164:469–474
Lautz TB, Kim ST, Donaldson JS, Superina RA (2012) Outcomes of percutaneous interventions for managing stenosis after meso-rex bypass for extrahepatic portal vein obstruction. J Vasc Interv Radiol 23:377–383
Lillegard JB, Hanna AM, McKenzie TJ et al (2010) A single-institution review of portosystemic shunts in children: an ongoing discussion. HPB Surg 2010:964597
Orloff MJ, Orloff MS, Rambotti M (1994) Treatment of bleeding esophagogastric varices due to extrahepatic portal hypertension: results of portal-systemic shunts during 35 years. J Pediatr Surg 29:142–154
Shim DJ, Ko G-Y, Sung K-B et al (2018) Long-term outcome of portal vein stent placement in pediatric liver transplant recipients: a comparison with balloon angioplasty. J Vasc Interv Radiol 29:800–808
Woerner A, Shivaram G, Koo KSH et al (2018) Clinical and imaging predictors of surgical splenorenal shunt dysfunction in pediatric patients. J Pediatr Gastroenterol Nutr 66:e139–e145
Acknowledgments
The drawings in Fig. 1 were created by Kate Sweeney, medical illustrator, Seattle, WA.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Stein, E.J., Shivaram, G.M., Koo, K.S.H. et al. Endovascular treatment of surgical mesoportal and portosystemic shunt dysfunction in pediatric patients. Pediatr Radiol 49, 1344–1353 (2019). https://doi.org/10.1007/s00247-019-04458-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-019-04458-6